NCT03375320
Clinical Trial Information
Trial Number: NCT03375320 (ClinicalTrials.gov)
Disease Type:
- Endocrine Neoplasm - Neuroendocrine Cancer
Trial Title:
"Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)"
Study ID:
A021602
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®